Home › Stocks › BLRX › Changes

Who bought & sold BLRX (Q3 2026)

Funds holding (Q3 2026)17
New positions5
Added4
Reduced2
Exited3

As of Q3 2026, 17 institutional funds reported holding BLRX (BIOLINE RX LIMITED): 5 opened new positions, 4 added, 2 trimmed and 3 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (5)

Fund Shares Value Weight
ARMISTICE CAPITAL, LLC New 473.00K $1.11M 0.0
STIFEL FINANCIAL CORP New 20.04K $47.10K —
SIMPLEX TRADING, LLC New 200 $470 —
Tower Research Capital LLC (TRC) New 181 $425 —
Caitong International Asset Management Co., Ltd New 2 $5 —

Added to positions (4)

Fund Shares Value Weight Change
Citadel Advisors 30.09K $70.70K — +15.29K sh (+103.3%)
Renaissance Technologies 18.90K $44.41K — +3.49K sh (+22.6%)
UBS Group AG 157 $369 — +56 sh (+55.4%)
OSAIC HOLDINGS, INC. 51 $119 — +25 sh (+96.2%)

Reduced positions (2)

Fund Shares Value Weight Change
SUSQUEHANNA INTERNATIONAL GROUP, LLP 20.55K $48.30K — -10.36K sh (-33.5%)
Wells Fargo & Co 1.75K $4.11K — -250 sh (-12.5%)

Exited positions (3)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
Banque Cantonale Vaudoise Exited 1 $1.00M —
BNP PARIBAS FINANCIAL MARKETS Exited 500 $1.55K —
Citigroup Inc Exited 1 $3 —